
Hyperfusion.ai uses AI to analyze DCE-imaging to provide faster feedback on cancer treatment. The company operates in bioinformatics and medical imaging, applying its AI capabilities to DCE-imaging to support oncology clinicians. Its technology centers on AI, DCE-imaging, and bioinformatics for healthcare providers. Its primary customers are medical professionals and healthcare institutions seeking faster treatment feedback. The company targets the oncology imaging market and aims to scale through clinical deployments and collaborations.

Hyperfusion.ai uses AI to analyze DCE-imaging to provide faster feedback on cancer treatment. The company operates in bioinformatics and medical imaging, applying its AI capabilities to DCE-imaging to support oncology clinicians. Its technology centers on AI, DCE-imaging, and bioinformatics for healthcare providers. Its primary customers are medical professionals and healthcare institutions seeking faster treatment feedback. The company targets the oncology imaging market and aims to scale through clinical deployments and collaborations.